Strongyloides Antibody, IgG by ELISA, Serum
Also known as: STRONGY
Use
This test aids in the diagnosis of Strongyloides infection. The presence of IgG antibodies to Strongyloides in the serum may suggest either a current or past infection. However, a positive result in patients from endemic areas may not necessarily indicate active infection. It is important to consider the patient's clinical presentation and history when interpreting results.
Special Instructions
Interpretive information highlights that false-positive results may occur with prior exposure to other helminth infections. Also, testing low-prevalence populations might yield false-positive results. It is recommended to retest the patient in 2-4 weeks if clinically indicated, particularly if the initial result is equivocal.
Limitations
The test may yield false-positive results if there has been prior exposure to other helminth infections. Additionally, testing populations with low prevalence of the disease may result in false-positive results. It is important to correlate test results with patient history and clinical findings to ensure accurate diagnosis.
FDA ApprovedNew York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 34376-4
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Container
Serum separator tube (SST) or plain red.
Storage Instructions
Refrigerated.
Causes for Rejection
Bacterially contaminated, heat-inactivated, hemolyzed, icteric, or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |